Back to search

Article

Circulating Tumor DNA in Genitourinary Malignancies: Current Applications and Future Perspectives

2025-06-12

Abstract excerpt

Circulating tumor DNA (ctDNA) analysis, a cornerstone of liquid biopsy, is rapidly emerging as a transformative tool in the management of genitourinary (GU) malignancies. This review synthesizes the current evidence-based clinical utility, critical challenges, and future perspectives of ctDNA across the spectrum of major GU cancers—including prostate, urothelial, renal cell, and testicular germ cell tumors. We exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94d94204-ab0c-52a2-98bd-37b8d6e46b80
DOI
10.20944/preprints202506.0995.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating Tumor DNA in Genitourinary Malignancies: Current Applications and Future PerspectivesDOI 10.20944/preprints202506.0995.v1
Liquid Biopsy in Genitourinary Cancers: Circulating Tumor DNA as a Predictive Biomarker for Treatment Selection and Resistance MonitoringSemantic proximity
Circulating tumor DNA: current challenges for clinical utility.Semantic proximity
Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays.Semantic proximity
Exploring the Role of Circulating Cell-Free DNA in Disease Diagnosis and TherapySemantic proximity
Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)Semantic proximity
Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.Semantic proximity
A clinician's handbook for using ctDNA throughout the patient journey.Semantic proximity
Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity
Clinical applications of cell-free DNA-based liquid biopsy analysisSemantic proximity
Integrated Plasma and Urinary Cell-free DNA Profiling Enables Noninvasive Molecular Detection from Ta to T4 Bladder CancerSemantic proximity
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity
Select a neighboring publication to make it the new centre.